High titers of autoantibodies in patients with sickle-cell disease

Journal of Rheumatology

Volumn 38, Issue 2, 2011, Pages 302-309

  Toly Ndour, Cécile ^a   Rouquette, Anne Marie ^a   Obadia, Stéphanie ^a   M'Bappe, Pauline ^a   Lionnet, François ^a   Hagege, Isabelle ^a   Boussa Khettab, Faiza ^a   Tshilolo, Léon ^b   Girot, Robert ^a  

^a HÔPITAL TENON   (France)

^b Monkole Medical Center   (Congo)

Author keywords

Autoantibodies; Autoimmune disease; Inflammation; Rheumatoid arthritis; Sickle cell anemia; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CARDIOLIPIN ANTIBODY; RHEUMATOID FACTOR;

ADOLESCENT; ADULT; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEROPREVALENCE; SICKLE CELL ANEMIA;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; AUTOANTIBODIES; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 79551711214     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.100667     Document Type: Article

References (49)

1. Stuart MJ, Nagel RL. Sickle-cell disease. Lancet 2004; 364:1343-60.
2. Bjornson AB. The immune deficit. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, editors. Sickle cell disease: basic principles and clinical practice. New York: Raven Press; 1994:335-44.
3. Baethge BA, Bordelon TR, Mills GM, Bowen LM, Wolf RE, Bairnsfather L. Antinuclear antibodies in sickle cell disease. Acta Haematol 1990;84:186-9.
4. Quismorio FP Jr, Johnson C. Serum autoantibodies in patients with sickle cell anemia. Am J Med Sci 1984;287:13-5. (Pubitemid 14171566)
5. De Ceulaer K, Khamashta MA, Harris EN, Serjeant GR, Hughes GRV. Antiphospholipid antibodies in homozygous sickle cell disease. Ann Rheum Dis 1992;51:671-2.
6. Kucuk O, Gilman-Sachs A, Beaman K, Lis LJ, Westerman MP. Antiphospholipid antibodies in sickle cell disease. Am J Hematol 1993;42:380-3. (Pubitemid 23104810)
7. Nistala K, Murray KJ. Co-existent sickle cell disease and juvenile rheumatoid arthritis. Two cases with delayed diagnosis and severe destructive arthropathy. J Rheumatol 2001;28:2125-8. (Pubitemid 32803795)
8. Marino C, McDonald E. Rheumatoid arthritis in a patient with sickle cell disease. J Rheumatol 1990;17:970-2. (Pubitemid 20243740)
9. Michel M, Habibi A, Godeau B, Bachir D, Lahary A, Galacteros F, et al. Characteristics and outcome of connective tissue diseases in patients with sickle-cell disease: report of 30 cases. Semin Arthritis Rheum 2008;38:228-40.
10. Cherner M, Isenberg D. The overlap of systemic lupus erythematosus and sickle cell disease: report of two cases and a review of the literature. Lupus 2010;19:875-83.
11. Herrmann M, Winkler T, Gaipl U, Lorenz HM, Geiller T, Kalden JR. Etiopathogenesis of systemic lupus erythematosus. Int Arch Allergy Immunol 2000;123:28-35.
12. Khalidi NA, Ajmani H, Varga J. Coexisting systemic lupus erythematosus and sickle cell disease: a diagnostic and therapeutic challenge. J Clin Rheumatol 2005;11:86-92.
13. Flanagan G, Packham DK, Kincaid-Smith P. Sickle cell disease and the kidney. Am J Kidney Dis 1993;21:325-7.
14. Couillard S, Benkerrou M, Girot R, Brousse V, Ferster A, Bader-Meunier B. Steroid treatment in children with sickle-cell disease. Haematologica 2007;92:425-6.
15. Urowitz MB, Gladman DD. Evolving spectrum of mortality and morbidity in SLE. Lupus 1999;8:253-5.
16. Fessel WJ. Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. Arch Intern Med 1974;134:1027-35.
17. McCarty DJ, Manzi S, Medsger TA Jr, Ramsey-Goldman R, LaPorte RE, Kwoh CK. Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum 1995;38:1260-70.
18. Symmons DP. Frequency of lupus in people of African origin. Lupus 1995;4:176-8.
19. Hopkinson ND, Doherty M, Powell RJ. Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients. Ann Rheum Dis 1994;53:675-80. (Pubitemid 24330603)
20. Lau CS, Yin G, Mok MY. Ethnic and geographical differences in systemic lupus erythematosus: an overview. Lupus 2006;15:715-9.
21. Aho K, Koskela P, Mäkitalo R, Heliövaara M, Palosuo T. Antinuclear antibodies heralding the onset of systemic lupus erythematosus. J Rheumatol 1992;19:1377-9.
22. Aho K, Heliovaara M, Maatela J, Tuomi T, Palosuo T. Rheumatoid factors antedating clinical rheumatoid arthritis. J Rheumatol 1991;18:1282-4.
23. Shmerling RH. Autoantibodies in systemic lupus erythematosus - there before you know it. N Engl J Med 2003;349:1499-500.
24. Wiik A. Antinuclear antibodies: clinical utility for diagnosis, prognosis, monitoring and planning of treatment strategy in systemic immune inflammatory diseases. Scand J Rheumatol 2005;34:260-8.
25. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
26. Van Boekel MA, Vossenaar ER, van den Hoogen FH, van Venrooij WJ. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res 2002;4:87-93. (Pubitemid 34257342)
27. Tan EM, Feltkamp TE, Smolen JS, Butcher B, Dawkins R, Fritzler MJ, et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum 1997;40:1601-11.
28. Vila P, Hernandez MC, Lopez-Fernandez MF, Batlle J. Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects. Thromb Haemost 1994;72:209-13. (Pubitemid 24251281)
29. Adebajo AO. Immunology and immunogenetics of rheumatologic disease in a tropical country. Rev Rheum 2002;69:777-90.
30. Greenwood BM, Muller AS, Valkenburg HA. Rheumatoid factor in Nigerian sera. Clin Exp Immunol 1971;9:161-73.
31. Greenwood BM. Autoimmune disease and parasitic infections in Nigerians. Lancet 1968;2:380-2.
32. Molokhia M, McKeigue PM, Cuadrado M, Hughes G. Systemic lupus erythematosus in migrants from West Africa compared with Afro-Caribbean people in the UK. Lancet 2001;357:1414-5. (Pubitemid 32455373)
33. Molokhia M, McKeigue P. Risk for disease in relation to ethnicity and admixture. Arthritis Res 2000;2:115-25. (Pubitemid 32223708)
34. Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997;89:1121-32.
35. Helley D, Girot R, Guillin MC, Bezeaud A. Sickle cell disease: relation between procoagulant activity of red blood cells from different phenotypes and in vivo blood coagulation activation. Br J Haematol 1997;99:268-72. (Pubitemid 27497550)
36. Bei R, Masuelli L, Palumbo C, Modesti M, Modesti A. A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: inflammation in their induction and impact on tumor growth. Cancer Lett 2009;281:8-23.
37. Distler JH, Pisetsky DS, Huber LC, Kalden JR, Gay S, Distler O. Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases. Arthritis Rheum 2005;52:3337-48. (Pubitemid 41612200)
38. Johnston RB Jr, Newman SL, Struth AG. An abnormality of the alternate pathway of complement activation in sickle-cell disease. N Engl J Med 1973;288:803-8.
39. Wilson WA, Hughes GR, Lachmann PJ. Deficiency of factor B of the complement system in sickle cell anaemia. Br Med J 1976;1:367-9.
40. Hernandez DE, Gonzalez N, Rios R, Merchan L, Wuani H. Phagocytosis in patients with sickle cell disease. J Clin Lab Immunol 1983;12:137-40. (Pubitemid 14242712)
41. Winkelstein JA, Drachman RH. Deficiency of pneumococcal serum opsonizing activity in sickle-cell disease. N Engl J Med 1968;279:459-66.
42. Baecher-Allan C, Hafler DA. Human regulatory T cells and their role in autoimmune disease. Immunol Rev 2006;212:203-16.
43. Sloma I, Zilber MT, Charron D, Girot R, Tamouza R, Gélin C. Upregulation and atypical expression of the CD1 molecules on monocytes in sickle cell disease. Hum Immunol 2004;65:1370-6.
44. Lleo A, Invernizzi P, Gao B, Podda M, Gershwin ME. Definition of human autoimmunity - autoantibodies versus autoimmune disease. Autoimmun Rev 2010;9:A259-66.
45. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526-33.
46. Shepshelovich D, Shoenfeld Y. Prediction and prevention of autoimmune diseases: additional aspects of the mosaic of autoimmunity. Lupus 2006;15:183-90.
47. Wilson WA, Nicholson GD, Hughes GR, Amin S, Alleyne G, Serjeant GR. Systemic lupus erythematosus and sickle-cell anaemia. Br Med J 1976;1:813.
48. Marino C, McDonald E. Rheumatoid arthritis in a patient with sickle cell disease. J Rheumatol 1990;17:970-2.
49. Katsanis E, Hsu E, Luke KH, McKee JA. Systemic lupus erythematosus and sickle hemoglobinopathies: a report of two cases and review of the literature. Am J Hematol 1987;25:211-4.